Therefore, to analyze the clinical implication of CLDN11 methylation to CRC, we obtained the progression free survival (PFS) data, along with the methylation data of CRC from TCGA (Supplementary Table 3). The gene discussed is CLDN11; the disease is colorectal carcinoma.